Dr. Larry Kessler, ScD, is the Director of Regulatory Oversight for the Center for Dialysis Innovation, and Professor in the Department of Health Services in the School of Public Health at the University of Washington. He has over 30 years of experience in health services research. He came to the University of Washington from US Food and Drug Administration (FDA) where he served as the director of both the Office of Surveillance and Biometrics and the Office of Science and Engineering Laboratories at the Center for Devices and Radiological Health. Dr. Kessler’s work in cancer surveillance with the Applied Research Branch at NCI substantially changed the way in which cancer surveillance is performed, with the addition of the Cancer supplements to the National Health Interview Survey, the SEER-Medicare data system, and the Breast Cancer Screening Consortium and the Breast Cancer Surveillance Consortium. He has an extensive research record in applied health services research with special work in cancer, in cancer surveillance research, and regulatory knowledge of medical products. Dr. Kessler’s recent research has broadened this into related fields of comparative effectiveness, patient centered and outcomes research. His recent work has focused on use of technologies in medical care. He is currently involved with several randomized trials and observational studies of comparative effectiveness and patient- centered outcomes research.